SLC5A2 and poliomyelitis: This case series from an LMIC describes three patients with type 2 diabetes mellitus and multiple comorbidities, including hypertension, ischemic stroke, chronic kidney disease, and poliomyelitis developed EuDKA associated with SGLT2 inhibitor (SGLT2i) use.